Literature DB >> 3565430

Bacteremia and fungemia in patients with neoplastic disease.

E Whimbey, T E Kiehn, P Brannon, A Blevins, D Armstrong.   

Abstract

This study reviewed 431 episodes of septicemia occurring in 356 patients with cancer at Memorial Sloan-Kettering Cancer Center during 1982. The most frequent organisms causing 273 episodes in 239 non-neutropenic patients were Escherichia coli (20 percent), Staphylococcus aureus (13 percent), polymicrobic (12 percent), Pseudomonas species (8 percent), Klebsiella species (7 percent), Candida species (7 percent), Bacteroides species (6 percent), Enterobacter species (4 percent), and Clostridium species (4 percent). The overall mortality was 31 percent (21 percent with adequate therapy; 50 percent with inadequate therapy). The most frequent organisms causing 158 episodes in 117 neutropenic patients were polymicrobic (21 percent), E. coli (16 percent), Klebsiella species (15 percent), Pseudomonas species (8 percent), Candida species (6 percent), S. aureus (6 percent), Streptococcus faecalis (5 percent), S. epidermidis (4 percent), and Corynebacterium CDC-JK (3 percent). The overall mortality was 52 percent (36 percent with adequate therapy; 88 percent with inadequate therapy). Since a review a decade ago, the spectrum of organisms changed in that the gram-positive organisms, S. faecalis, S. epidermidis, and C. CDC-JK, emerged as important pathogens. Neutropenic patients had a high incidence (42 percent) of septicemia due to multiple organisms, occurring concurrently or sequentially. The overall mortality of these patients was exceptionally high (80 percent). In contrast, the overall mortality of neutropenic patients with single-organism septicemia was comparable to that of non-neutropenic patients with single-organism septicemia (37 percent versus 29 percent).

Entities:  

Mesh:

Year:  1987        PMID: 3565430     DOI: 10.1016/0002-9343(87)90007-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  26 in total

1.  Candida endophthalmitis: clinical presentation, treatment and outcome in 23 patients.

Authors:  S Schmid; A C Martenet; O Oelz
Journal:  Infection       Date:  1991 Jan-Feb       Impact factor: 3.553

2.  Nocturnal hypoxemia and oxygen desaturation events in neutropenic patients with sepsis or pneumonia.

Authors:  M von Eiff; E Grone; C Herbort; M Zuhlsdorf; J Van de Loo
Journal:  Intensive Care Med       Date:  1996-02       Impact factor: 17.440

3.  Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin.

Authors:  F Brunet; G Vedel; F Dreyfus; J F Vaxelaire; T Giraud; B Schremmer; J F Monsallier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

4.  Detection and identification of fungal pathogens in blood by using molecular probes.

Authors:  H Einsele; H Hebart; G Roller; J Löffler; I Rothenhofer; C A Müller; R A Bowden; J van Burik; D Engelhard; L Kanz; U Schumacher
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

Review 5.  Outpatient antibiotic treatment in low-risk febrile neutropenic cancer patients.

Authors:  C P Escalante; E B Rubenstein; K V Rolston
Journal:  Support Care Cancer       Date:  1996-09       Impact factor: 3.603

6.  Quantification and optimization of Candida albicans DNA in blood samples using Real- Time PCR.

Authors:  Mojtaba Nabili; Mohsen Ashrafi; Ghasem Janbabaie; Mohamad Taghi Hedayati; Kamran Ali-Moghaddam; Tahereh Shokohi
Journal:  Rep Biochem Mol Biol       Date:  2013-10

Review 7.  [Hemorrhage, shock and infection].

Authors:  H Graeff; R Deckardt
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

8.  Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution.

Authors:  E González-Barca; A Fernández-Sevilla; J Carratalá; A Grañena; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

Review 9.  Bacteremia and fungemia in the immunocompromised patient.

Authors:  T E Kiehn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

10.  Rapid detection of Candida albicans in clinical blood samples by using a TaqMan-based PCR assay.

Authors:  Younes Maaroufi; Corine Heymans; Jean-Marc De Bruyne; Valerie Duchateau; Hector Rodriguez-Villalobos; Michel Aoun; Françoise Crokaert
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.